UNICA IRIS Institutional Research Information System

MACCIONI, ELIAS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 308.052
NA - Nord America 12.900
AS - Asia 5.486
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 541
AF - Africa 198
OC - Oceania 6
Totale 327.959
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 304.460
US - Stati Uniti d'America 12.683
SG - Singapore 2.097
CN - Cina 2.032
UA - Ucraina 952
SE - Svezia 823
BR - Brasile 593
DE - Germania 477
VN - Vietnam 438
FI - Finlandia 428
GB - Regno Unito 280
FR - Francia 264
HK - Hong Kong 168
IN - India 167
CA - Canada 124
BD - Bangladesh 121
KR - Corea 100
MA - Marocco 77
NL - Olanda 64
AR - Argentina 62
PK - Pakistan 52
IQ - Iraq 50
MX - Messico 50
RU - Federazione Russa 50
AT - Austria 46
JP - Giappone 39
TR - Turchia 38
PL - Polonia 36
ZA - Sudafrica 36
ES - Italia 30
EC - Ecuador 29
IE - Irlanda 28
ID - Indonesia 27
SA - Arabia Saudita 27
CO - Colombia 25
BE - Belgio 24
VE - Venezuela 24
KE - Kenya 19
PH - Filippine 19
TN - Tunisia 17
EG - Egitto 16
CL - Cile 14
IR - Iran 14
LT - Lituania 14
CZ - Repubblica Ceca 13
CR - Costa Rica 12
UZ - Uzbekistan 12
NP - Nepal 11
PY - Paraguay 11
JO - Giordania 10
RO - Romania 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
PT - Portogallo 9
ET - Etiopia 8
PA - Panama 8
PE - Perù 8
AL - Albania 7
EU - Europa 7
HU - Ungheria 7
JM - Giamaica 7
BO - Bolivia 6
MY - Malesia 6
KG - Kirghizistan 5
MD - Moldavia 5
MU - Mauritius 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
KW - Kuwait 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
GE - Georgia 3
NG - Nigeria 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TW - Taiwan 3
UY - Uruguay 3
BB - Barbados 2
BN - Brunei Darussalam 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
IS - Islanda 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
A1 - Anonimo 1
AM - Armenia 1
AW - Aruba 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
Totale 327.403
Salva come PNG Salva come JPEG
Città #
Cagliari 298.440
Uta 5.289
Singapore 1.095
Ashburn 1.038
Fairfield 990
Chandler 875
Woodbridge 849
San Jose 769
Dallas 672
Houston 653
Boardman 546
Ann Arbor 531
Nyköping 529
Jacksonville 497
Beijing 417
Wilmington 412
Seattle 406
Dearborn 379
Cambridge 303
Helsinki 277
Los Angeles 243
Council Bluffs 225
New York 221
Santa Clara 198
Nanjing 171
The Dalles 169
Lauterbourg 152
Hong Kong 149
Shanghai 148
Boston 140
Ho Chi Minh City 137
Hefei 133
Seoul 97
Hanoi 93
Buffalo 79
Casablanca 64
Redwood City 64
Shenyang 61
Guangzhou 55
Nanchang 54
Dong Ket 53
Munich 52
San Diego 52
São Paulo 52
Orem 50
Toronto 49
Milan 48
Amsterdam 47
Jiaxing 42
Changsha 41
Hebei 41
Verona 41
Frankfurt am Main 39
Chicago 38
Sassari 38
Chennai 34
Jinan 34
Montreal 34
Phoenix 34
Tianjin 34
Warsaw 34
London 32
Vienna 30
Atlanta 29
Mountain View 29
Kunming 28
Redondo Beach 28
Tokyo 28
Columbus 26
Brooklyn 25
Rome 25
Herndon 24
Norwalk 24
Dublin 23
Johannesburg 22
Washington 22
Brussels 21
Mumbai 20
Zhengzhou 20
Hangzhou 19
San Francisco 19
Auburn Hills 18
Nuremberg 18
Pune 18
Nairobi 17
Orange 17
Taizhou 17
Baghdad 16
Denver 15
Manchester 15
Ningbo 15
Rio de Janeiro 15
Wuhan 15
Da Nang 14
Lahore 14
Mexico City 14
Haiphong 13
Dhaka 12
Guayaquil 12
Stockholm 12
Totale 319.288
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro- 1H -indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 14.733
Exploring the thiazole scaffold for the identification of new agents for the treatment of fluconazole resistant Candida 5.069
Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro, and in vivo studies 4.712
Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders 4.708
Natural product-inspired esters and amides of ferulic and caffeic acid as dual inhibitors of HIV-1 reverse transcriptase 4.695
Design, synthesis, and biological evaluation of 1,3-diarylpropenones as dual inhibitors of HIV-1 reverse transcriptase 4.542
Quercetin blocks Ebola Virus infection by counteracting the VP24 Interferon inhibitory function 4.495
Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors 4.451
2-(2-cycloalkylidene hydrazin-1-yl)-4-aryl-1,3-thiazoles: a promising class of antifungal agents 4.421
Lactoferrin- and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: Preparation and in vivo evaluation 4.382
Ribonuclease H/DNA polymerase HIV-1 reverse transcriptase dual inhibitor: mechanistic studies on the allosteric mode of action of isatin-based compound RMNC6 4.337
3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: A new scaffold for the selective inhibition of monoamine oxidase B 4.332
Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase 4.198
N-Alkyl dien- and trienamides from the roots of Otanthus maritimus with binding affinity for opioid and cannabinoid receptors 3.952
New 4-[(3-cyclohexyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzene-1-sulfonamides, synthesis and inhibitory activity toward carbonic anhydrase I, II, IX, XII 3.948
A novel series of 3,4-disubstituted dihydropyrazoles: Synthesis and evaluation for MAO enzyme inhibition 3.788
Drug design, synthesis, in vitro and in silico evaluation of selective monoaminoxidase B inhibitors based on 3-acetyl-2-dichlorophenyl-5-aryl-2,3-dihydro-1,3,4-oxadiazole chemical scaffold 3.788
Identification of Myricetin as Ebolavirus VP35-dsRNA interaction inhibitor through a novel fluorescence-based assay 3.761
Ferulic Acid Esters and Withanolides: in Search of Withania somnifera GABAA Receptor Modulators 3.622
Targeting tumor associated carbonic anhydrase IX and XII: Highly isozyme selective coumarin and psoralen inhibitors 3.547
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 3.499
Sennoside A, derived from the traditional chinese medicine plant Rheum L., is a new dual HIV-1 inhibitor effective on HIV-1 replication 3.446
Coumarins from Magydaris pastinacea as inhibitors of the tumour-associated carbonic anhydrases IX and XII: isolation, biological studies and in silico evaluation 3.435
N-alkylamides from Otanthus maritimus: structure elucidation, binding affinity for cannabinoid receptors and computational study 3.432
Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase B 3.385
Molecular Aspects of the RT/drug Interactions. Perspective of Dual Inhibitors 3.319
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 3.318
Multi-target activity of Hemidesmus indicus decoction against innovative HIV-1 drug targets and characterization of Lupeol mode of action 3.304
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B 3.299
Synthesis of new 3-aryl-4,5-dihydropyrazole-1-carbothioamide derivatives. An investigation on their ability to inhibit monoamine oxidase 3.231
N-Acylbenzenesulfonamide dihydro-1,3,4-oxadiazole hybrids: seeking selectivity toward carbonic anhydrase isoforms 3.217
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 3.120
Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors 3.114
Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides 3.054
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Dual Inhibitors of HIV-1 RT. 3.048
Investigating the Anticancer Activity of Isatin/Dihydropyrazole Hybrids 3.046
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) enlighten the mechanism of action of a new Ribonuclease H/DNA polymerase RT dual inhibitor 2.987
Design, Synthesis and Biological Evaluation of New 1,3-Diarylpropenones as Single Site Dual Inhibitors of HIV-1 RT 2.939
Site directed mutagenesis studies on HIV-1 reverse transcriptase (RT) shed light on the mechanism of action of a new Ribonuclease H/ DNA polymerase RT dual inhibitor 2.931
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 2.873
MD protocol validation for the study of MAOB-inhibitor complexes 2.790
Mutagenic study on HIV-1 reverse transcriptase to explore the mechanism of action of HIV-1 reverse transcriptase dual inhibitors 2.780
In search of new antitumor agents through the combination of individually active moieties: construction of a [3,5-diaryl-(4,5- dihydropyrazol-1-yl)-4-oxo-1,3-thiazol-5-ylidene]- 1H-indol-2-ones library 2.755
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 2.737
Synthesis and biological activity evaluation of new dual-inhibitors of both associated functions of HIV-1 RT 2.663
Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-telo and c-myc DNA G-quadruplex conformations 2.655
3-[2-(4-aryl-1,3-thiazol-2-yl)hydrazin-1-ylidene]-1H-indol-2-ones as new potential dual inhibitors of polimerase and ribonuclease HIV-1 RT associated function 2.625
Towards the total block of HIV-1 Reverse Transcriptase: the dual-inhibitors approach 2.615
Investigation on the mechanism of action of new dual inhibitors of HIV-1 RT 2.555
Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases 2.555
Synthesis and characterization of new phthalhydrazothiazole derivatives: A preliminary investigation on their activity against hepatocellular carcinoma 2.549
Chalcones as novel dual inhibitors of HIV-1 reverse transcriptase 2.471
New dual inhibitors of RT associated functions: investigation on their mechanism and mode of action 2.460
Meeting report: Fourth Summer School on Innovative Approaches for Identification of Antiviral Agents (IAAASS) 2.441
New promising scaffolds for the inhibition of monoamine oxidase B 2.318
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 2.303
Exploring new scaffolds for the inibition of the Ribonuclease H function of RT HIV-1 2.280
Terapia delle infezioni sostenute da Candida spp.: nuovi approcci mediante derivati isotiosemicarbazonici. 2.189
Isatin derivatives as new scaffolds for HIV-1 reverse transcriptase associated RNase H and RDDP dual inhibitors 2.155
Meeting report: Third Summer School on innovative approaches for identification of antiviral agents (IAAASS) 2.118
In vitro activity of 2-cyclohexylidenhydrazo-4-phenil-thiazole compared with those of amphotericin b and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans 2.117
Design, synthesis and biolgical activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 2.097
Identification of HIV-1 reverse transcriptase dual inhibitors by a combined shape-, 2D-fingerprint- and pharmacophore-based virtual screening approach 2.090
Design, synthesis and biological activity evaluation of c-myc proto-oncogene binders as potential antitumor agents 2.082
Design, synthesis and biological activity evaluation of new HIV-1 reverse transcriptase dual inhibitors 1.985
null 1.949
Synthesis and anti-microbial activity evaluation of some new 1-benzoyl-isothiosemicarbazides. 1.942
New reactions of carbon suboxide with alkines 1.937
Identification of HIV-1 reverse trascriptase dual inhibitors by a combined shape-, 2D fingerprint and pharmacophore-based virtual screening approch 1.937
Semipreparative HPLC enantioseparation, chiroptical properties, and absolute configuration of two novel cyclooxygenase-2 inhibitors 1.905
Design of new inhibitors of the HIV-1 Reverse Transcriptase associated Ribonuclease H function: a synthetic approach 1.893
Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors 1.874
Brain delivery of the NK3 receptor agonist senktide by immunoliposome: an in vivo microdialysis study 1.834
Identification of new scaffolds for the inhibition of HIV-1 Reverse Transcriptase associated Ribonuclease H function by means of shape based similarity screening 1.822
SITE DIRECT MUTAGENESIS AND KINETIC STUDIES TO EXPLORE THE MECHANISM OF ACTION OF ISATIN DERIVATIVES AS HIV-1 REVERSE TRANSCRIPTASE DUAL INHIBITORS 1.810
Application of an immobilised amylose-based chiral stationary phase to the development of new monoamine oxidase B inhibitors 1.793
New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII 1.746
Exploring new scaffolds for the inhibition of the Ribonuclease H function of RT HIV-1 1.716
SYNTHESIS, MOLECULAR MODELLING, INHIBITORY ACTIVITY, AND SELECTIVITY TOWARDS MONOAMINE OXIDASE OF NEW HETEROCYCLIC SCAFFOLDS 1.693
Synthesis and anti-microbial activity of isothiosemicarbazones and cyclic analogues 1.676
Synthesis and antimicrobial activity of novel arylidenisothiosemicarbazones 1.670
Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey 1.649
Flavonoids and Acid-Hydrolysis derivatives of Neo-Clerodane diterpenes from Teucrium flavum subsp. glaucum as inhibitors of the HIV-1 reverse transcriptase–associated RNase H function 1.643
Synthesis and biological evaluation of new dual inhibitors of HIV-1 associated functions 1.618
Effetti sulla attività di AmB nei confronti di biofilm di C. albicans in seguito ad esposizione a EM01D2 e fluconazolo. 1.601
From classic to innovative approaches in HIV-1 infection treatment 1.571
null 1.499
Derivati ciclici isotiosemicarbazonici come approccio alternativo nella terapia delle infezioni sostenute da Candida spp. 1.480
Shape based computer aided similarity screening: a valid tool in the discovery of new scaffolds for the inhibition of HIV-1 reverse transcriptase associated ribonuclease H function 1.439
null 1.415
null 1.406
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 1.340
The preparation of non ionic surfactant vesicles formed from hexacyclophosphazenic derivatives 1.299
9-fluorenones as new scaffolds for G-quadruplex DNA 1.248
Exploring new scaffolds for the dual inhibition of HIV-1 RT polymerase and ribonuclease associated functions 1.213
Synthesis of new arylidencycloalkylpyrazoles of potential biological interest 1.202
A combined shape-, 2D-fingerprint-and pharmacophore-based virtual screening for the identification of dual inhibitors targeting HIV-1 reverse transcriptase. 1.189
An investigation of the biological effect of structural modifications of isothiosemicarbazones and their cyclic analogues 1.138
Design, synthesis and biological evaluation of new fluorenone derivatives as DNA G-quadruplex binders 1.138
The biologically active compound of Withania somnifera (L.) Dunal, docosanyl ferulate, is endowed with potent anxiolytic properties but devoid of typical benzodiazepine-like side effects 1.130
Totale 275.278
Salva come PNG Salva come JPEG
Categoria #
all - tutte 393.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 393.942
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202212.308 0 1.214 707 981 1.186 930 870 734 1.327 1.365 1.419 1.575
2022/202323.332 2.103 3.454 2.892 2.226 1.572 2.521 1.290 1.647 1.248 1.333 1.869 1.177
2023/202422.577 1.096 695 2.080 1.828 2.344 3.929 2.885 1.628 1.203 1.336 1.657 1.896
2024/202549.847 15.268 14.318 6.700 4.383 2.091 2.671 2.480 205 516 346 344 525
2025/202612.642 802 459 1.439 1.138 908 750 1.750 1.146 947 1.757 722 824
2026/2027689 266 423 0 0 0 0 0 0 0 0 0 0
Totale 327.959